Clinical Trial Update: Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ponatinib in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia, including MRD-positive and relapsed disease; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Ponatinib (ponatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse | Phase 2 | Status: ACTIVE_NOT_RECRUITING